Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gülberg

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Gastroenterology|November 1, 1993
Differentiation of endothelin-1 and endothelin-3 concentrationsV Gülberg, A L Gerbes
Deutsche Medizinische Wochenschrift (1946)|February 21, 2003
[Pharmacological treatment of ascites and hepatorenal syndrome]V Gülberg, A L Gerbes
Der Internist|April 30, 1998
[Diagnosis and therapy of ascites in liver cirrhosis]V Gülberg, A L Gerbes
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Diagnosis and treatment of ascites]A L Gerbes, V Gülberg
European Journal of Clinical Investigation|August 22, 2006
Endothelin and endothelin receptor antagonism in portopulmonary hypertensionW Neuhofer, V Gülberg, A L Gerbes
Digestion|August 7, 1998
Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of endothelinsA L Gerbes, M Bilzer, V Gülberg
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 17, 2000
Determination of plasma adrenomedullin concentrations with commercial radioimmunoassay kits: a note of cautionV Gülberg, I Liss, A L Gerbes
Hepatology (Baltimore, Md.)|September 25, 1999
Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamineV Gülberg, M Bilzer, A L Gerbes
Digestion|August 27, 1998
Endothelin and other mediators in the pathophysiology of portal hypertensionA L Gerbes, V Gülberg, M Bilzer
Digestion|December 5, 2012
Intrarenal resistance index as a prognostic parameter in patients with liver cirrhosis compared with other hepatic scoring systemsM Götzberger, J Singer, C Kaiser, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Gastroenterology|November 1, 1993
Differentiation of endothelin-1 and endothelin-3 concentrationsV Gülberg, A L Gerbes
Deutsche Medizinische Wochenschrift (1946)|February 21, 2003
[Pharmacological treatment of ascites and hepatorenal syndrome]V Gülberg, A L Gerbes
Der Internist|April 30, 1998
[Diagnosis and therapy of ascites in liver cirrhosis]V Gülberg, A L Gerbes
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Diagnosis and treatment of ascites]A L Gerbes, V Gülberg
European Journal of Clinical Investigation|August 22, 2006
Endothelin and endothelin receptor antagonism in portopulmonary hypertensionW Neuhofer, V Gülberg, A L Gerbes
Digestion|August 7, 1998
Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of endothelinsA L Gerbes, M Bilzer, V Gülberg
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 17, 2000
Determination of plasma adrenomedullin concentrations with commercial radioimmunoassay kits: a note of cautionV Gülberg, I Liss, A L Gerbes
Hepatology (Baltimore, Md.)|September 25, 1999
Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamineV Gülberg, M Bilzer, A L Gerbes
Digestion|August 27, 1998
Endothelin and other mediators in the pathophysiology of portal hypertensionA L Gerbes, V Gülberg, M Bilzer
Digestion|December 5, 2012
Intrarenal resistance index as a prognostic parameter in patients with liver cirrhosis compared with other hepatic scoring systemsM Götzberger, J Singer, C Kaiser, et al.
Pageof 5